Permanently Discontinued

APO-BRIMONIDINE

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO-BRIMONIDINE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO-BRIMONIDINE 0.2% has been permanently discontinued (last updated December 28, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is APO-BRIMONIDINE not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength0.2%

Report last updated2018-12-28

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ALPHAGAN

ABBVIE CORPORATION

0.2% · DIN 02236876

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MED-BRIMONIDINE

GENERIC MEDICAL PARTNERS INC

0.2% · DIN 02507811

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOZ BRIMONIDINE

SANDOZ CANADA INCORPORATED

0.2% · DIN 02305429

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

RIVA-BRIMONIDINE

LABORATOIRE RIVA INC.

0.2% · DIN 02515350

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

ALPHAGAN P

ABBVIE CORPORATION

0.15% · DIN 02248151

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

LUMIFY

BAUSCH & LOMB INC

0.025% · DIN 02517698

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02260077

Strength

0.2%

Dosage Form

SOLUTION

Route

OPHTHALMIC

Active Ingredient

BRIMONIDINE TARTRATE

Tier

Unrated

Last Updated

2018-12-28

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-BRIMONIDINE has 2 shortage/discontinuation reports on file — this is one of them.

2020-11-16

Permanently Discontinued

Business reasons

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244